Patent directory · USPTO A61K / A61P
Patents matching “SION”
1,496 pharma patents match "SION" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,496 pharmaceutical patents matching "SION" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9839685
Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
granted -
US 9840549
Fusion polypeptides capable of activating receptors
granted -
US 9839698
Light-switchable gene expression system
granted -
US 9834587
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
granted -
US 9834588
Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
granted -
US 9827394
Dispersion anaesthetic device
granted -
US 9827202
Hot-melt extrusion of modified release multi-particulates
granted -
US 9822365
Compositions and methods for inhibiting expression of the PCSK9 gene
granted -
US 9816092
Modulation of transthyretin expression
granted -
US 9814867
Device having titania nanotube membrane for drug delivery
granted -
US 9814771
Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E2
granted -
US 9815872
Toxoid peptides derived from phenol soluble modulin, delta toxin, superantigens, and fusions thereof
granted -
US 9814755
Methods for the treatment of depression and anxiety
granted -
US 9808465
Emulsion formulations of aprepitant
granted -
US 9808505
Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)
granted -
US 9801887
Method of treatment of aggression
granted -
US 9801954
Lipid substitution on aminoglycoside based polymers: plasmid delivery, anticancer drug delivery and transgene expression
granted -
US 9801842
Nanoemulsion therapeutic compositions and methods of using the same
granted -
US 9804298
Ophthalmic lens material
granted -
US 9801911
Expansion of alloantigen-reactive regulatory T cells
granted -
US 9803205
Compositions and methods for inhibiting gene expression of factor XII
granted -
US 9796976
Methods and compositions for modulating alpha-1 antitrypsin expression
granted -
US 9796755
Methods of treating depression and other related diseases
granted -
US 9790261
Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
granted